HER2

Brief about this service

Provides HER2 status evaluation to support subtype and treatment-related decisions in relevant cases.

HER2 marker assessment as part of oncology biomarker workflows. Each case is processed under quality-controlled oncology diagnostics workflows for clinically meaningful output.

When this test is commonly used

• Oncology cases requiring focused pathology clarification.
• Clinician requests for marker-supported diagnostic confidence.
• Workflows where clear reporting and turnaround are both critical.

Sample and reporting guidance

Provide representative tissue sections or blocks with relevant histology context so marker interpretation can be correlated accurately with morphology.

Reports are structured for doctor readability with concise interpretation notes and pathway-oriented communication.